Table of Contents
Chapter 1. Executive Summary
1.1. Endocrine Function Diagnostics – Industry Summary and Critical Success Factors (CSFs)
Chapter 2. Endocrine Function Diagnostics Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Endocrine Function Diagnostics Market Dynamics
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Endocrine Function Diagnostics - Company Market Share Analysis
2.7. Endocrine Function Diagnostics Market PESTEL Analysis, 2012
Chapter 3. Endocrine Function Diagnostics Product Outlook
3.1. Cortisol
3.2. TSH
3.3. Progesterone
3.4. Free T3
3.5. Free T4
3.6. T4
3.7. Gastrin
3.8. LH
3.9. Estradiol
3.10. TPO Ab
3.11. HCG
3.12. T3
3.13. T3 uptake
3.14.甲状腺球蛋白Ab
3.15. Prolactin
3.16. FSH
3.17. TBG
3.18. PTH/IO
3.19. PTH
3.20. Testosterone
Chapter 4. Endocrine Function Diagnostics Regional Outlook
4.1. North America
4.2. Europe
4.3. Asia-Pacific
4.4. RoW
Chapter 5. Competitive Landscape
5.1. Revenue Analysis
5.2. Product Benchmarking
5.3. Strategic Development
Chapter 6. Methodology and Scope
6.1. Research Methodology
6.2. Research Scope & Assumption
6.3. List of Data Sources